ACE and obesity disorder: Inhibition of ACE, i.e. the blockade of AT1R and AT2R can be an interesting target for radioprotective therapy since it reduces oxidative stress and production of free radicals, which may indicate a protective anti-inflammatory effect in obesity, hypertension and other diseases, and reduction of damage caused by radiotherapy.